Abstract
Background
Direct measurement of in utero phthalate exposure in placental and fetal tissues is generally not possible. Maternal urinary levels serve as proxies and may introduce measurement error, biasing health effect estimates.
Objective
We adjusted for measurement error when using maternal urinary phthalates as proxies for placental–fetal exposure and to evaluate the impact of this correction on the association between prenatal phthalate exposure and anogenital distance (AGD).
Method
We biopsied and analyzed 68 placentas from the TIDES study (San Francisco site: n = 204, 2010–2012). Phthalate metabolite concentrations were measured in three placental tissue types: chorion smooth (CS), chorion frondosum (CF), and basal plate (BP). Phthalate concentrations were standardized to remove pre-processing variation. Regression calibration (RC) and multiple imputation for measurement error (MIME) were used for correction. Associations between phthalates and AGD were estimated by generalized linear models. Bias was quantified by calculating the percent change in the beta coefficient from the gold standard (placental phthalate) to the proxy (urinary phthalate), after correction for measurement error.
Results
Phthalate metabolites were detected in over 70% of placental tissues. Monoethylhexyl (MEHP) phthalate was the most abundant metabolite in CF and in CS. Phthalate concentrations were lowest in BP and varied across placental tissues. Weak associations were found between urinary and placental phthalates. MIME outperformed RC, reducing bias in the average phthalate effect on AGD in the male by 30% for AGD-penis and 69% for AGD-scrotum, and in the female by 32% for AGD-clitoris and 45% for AGD-fourchette.
Significance
Placental phthalate concentrations varied by tissue type and showed poor correlation with maternal urinary levels. MIME outperformed RC in adjusting for measurement error in this setting. Findings suggest maternal and placental exposures are distinct constructs, highlighting the need for direct placental measurement in phthalate toxicity studies. Further research can improve phthalate exposure assessment and knowledge of maternal-placental-fetal transfer.
Impact
This study highlights a key gap in environmental health research, where maternal urinary phthalates are often used as proxies for placental and fetal exposure. Using two correction methods, we found that maternal urinary and placental phthalates represent distinct exposure constructs and are not interchangeable.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
Data availability
The data are available from the corresponding author on reasonable request.
References
White E. Measurement error in biomarkers: sources, assessment, and impact on studies. IARC Sci Publ. 2011;143–61.
Ratain MJ, Plunkett WK Jr. Principles of Pharmacokinetics. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC Jr, Gansler TS, Holland JF, Frei E III, editors. Holland-Frei Cancer Medicine. 6th edn. Hamilton: BC Decker; 2003.
Koch HM, Calafat AM. Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc Lond B Biol Sci. 2009;364:2063–78.
Zhang Y, Lin L, Cao Y, Chen B, Zheng L, Ge RS. Phthalate levels and low birth weight: a nested case-control study of Chinese newborns. J Pediatr. 2009;155:500–4.
Wittassek M, Angerer J, Kolossa-Gehring M, Schäfer SD, Klockenbusch W, Dobler L, et al. Fetal exposure to phthalates: a pilot study. Int J Hyg Environ Health. 2009;212:492–8.
Huang PC, Kuo PL, Chou YY, Lin SJ, Lee CC. Association between prenatal exposure to phthalates and the health of newborns. Environ Int. 2009;35:14–20.
Mose T, Knudsen LE, Hedegaard M, Mortensen GK. Transplacental transfer of monomethyl phthalate and mono(2-ethylhexyl) phthalate in a human placenta perfusion system. Int J Toxicol. 2007;26:221–9.
Liang HW, Snyder N, Wang J, Xun X, Yin Q, LeWinn K, et al. A study on the association of placental and maternal urinary phthalate metabolites. J Expo Sci Environ Epidemiol. 2023;33:264–72.
Mathew L, Snyder NW, Lyall K, Lee BK, McClure LA, Elliott AJ, et al. Prenatal phthalate exposure measurement: A comparison of metabolites quantified in prenatal maternal urine and newborn’s meconium. Sci Total Environ. 2021;796:148898.
Adibi JJ, Lee MK, Naimi AI, Barrett E, Nguyen RH, Sathyanarayana S, et al. Human chorionic gonadotropin partially mediates phthalate association with male and female anogenital distance. J Clin Endocrinol Metab. 2015;100:E1216–24.
Adibi JJ, Zhao Y, Koistinen H, Mitchell RT, Barrett ES, Miller R, et al. Molecular pathways in placental-fetal development and disruption. Mol Cell Endocrinol. 2024;581:112075.
Xun X, Qin X, Layden AJ, Yin Q, Swan SH, Barrett ES, et al. Application of 4-way decomposition to the analysis of placental-fetal biomarkers as intermediary variables between maternal body mass index and birthweight. Front Reprod Health. 2022;4:994436.
Adibi JJ, Layden AJ, Birru RL, Miragaia A, Xun X, Smith MC, et al. First-trimester mechanisms of gestational sac placental and foetal teratogenicity: a framework for birth cohort studies. Hum Reprod Update. 2021;27:747–70.
Nelson W, Liu DY, Yang Y, Zhong ZH, Wang YX, Ding YB. In utero exposure to persistent and nonpersistent endocrine-disrupting chemicals and anogenital distance. A systematic review of epidemiological studies. Biol Reprod. 2020;102:276–91.
Innes GK, Bhondoekhan F, Lau B, Gross AL, Ng DK, Abraham AG. The measurement error elephant in the room: challenges and solutions to measurement error in epidemiology. Epidemiol Rev. 2022;43:94–105.
Swan SH, Sathyanarayana S, Barrett ES, Janssen S, Liu F, Nguyen RHN, et al. First-trimester phthalate exposure and anogenital distance in newborns. Hum Reprod. 2015;30:963–72.
Kuiper JR, O’Brien KM, Ferguson KK, Buckley JP. Urinary specific gravity measures in the U.S. population: implications for the adjustment of non-persistent chemical urinary biomarker data. Environ Int. 2021;156:106656.
Mortamais M, Chevrier C, Philippat C, Petit C, Calafat AM, Ye X, et al. Correcting for the influence of sampling conditions on biomarkers of exposure to phenols and phthalates: a 2-step standardization method based on regression residuals. Environ Health. 2012;11:29.
Nab L, van Smeden M, Keogh RH, Groenwold RH. Mecor: an R package for measurement error correction in linear regression models with a continuous outcome. Comput Methods Prog Biomed. 2021;208:106238.
van Buuren S, Groothuis-Oudshoorn K. mice: multivariate Imputation by Chained Equations in R. J Stat Softw. 2011;45:1–67.
Martino-Andrade AJ, Liu F, Sathyanarayana S, Barrett ES, Redmon JB, Nguyen RHN, et al. Timing of prenatal phthalate exposure in relation to genital endpoints in male newborns. Andrology. 2016;4:585–93.
Marsh B, Zhou Y, Kapidzic M, Fisher S, Blelloch R. Regionally distinct trophoblasts regulate barrier function and invasion in the human placenta. Elife. 2022;11:e70027.
Menon R, Richardson LS, Lappas M. Fetal membrane architecture, aging and inflammation in pregnancy and parturition. Placenta. 2019;79:40–5.
Genbacev O, Donne M, Kapidzic M, Gormley M, Lamb J, Gilmore J, et al. Establishment of human trophoblast progenitor cell lines from the chorion. Stem Cells. 2011;29:1427–36.
Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Investig. 2008;118:1479–90.
Funding
This work was supported by NIH grants K99/R00ES017780, R01ES016863, and R01ES025169.
Author information
Authors and Affiliations
Contributions
HWL drafted the manuscript and performed the statistical analysis. NS conducted the phthalate analysis. JW provided statistical consultation. RB handled sample preprocessing. JC, KK, ESB, SS, and JJA reviewed and provided feedback on the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
Approval for this research was obtained from the UCSF Human Subjects Committee, at the Icahn School of Medicine at Mount Sinai, which served as the TIDES Coordinating Center after 2011, and the University of Pittsburgh Institutional Review Board.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liang, HW., Snyder, N., Wang, J. et al. An assessment of measurement error when using maternal urinary phthalates as proxies for placental tissue levels in the estimation of the association of prenatal phthalates and infant anogenital distance. J Expo Sci Environ Epidemiol (2026). https://doi.org/10.1038/s41370-026-00886-3
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41370-026-00886-3


